retatrutide clinical trials safety retatrutide study Eli Lilly infiltrates anti-obesity market as Phase III trial for begins Safety, Side Effects & – retatrutide dosage weight loss clinical

The most frequent side effects of GLP-1 medications are gastrointestinal issues such as nausea and vomiting [5]

In the retatrutide phase 2 trial at 48 weeks, the 12 mg group reported 100% of participants losing at least 5%, 93% losing at least 10%, and 83% losing at least 15% though this was a smaller, earlier-stage study

He wrote in his June letter to lawmakers that these drugs can cost $1,000 a month per person and that even temporary coverage could set expectations for long-term use that Louisiana simply cannot afford. The state Office of Group Benefits spends $200 million annually on GLP-1s for diabetes treatment alone and is adding people everyday, CEO Heath Williams told lawmakers at a September finance committee meeting

All six sides are equal All six angles measure 120 each Six lines of symmetry run through the center Always convex This is why our regular hexagon is also perfectly symmetrical

The World Health Organization issued a GLP-1 obesity-treatment guideline in December 2025